Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 05:54 ET | Source: Research and Markets

Breast Cancer Antibody Drug Conjugates Market Research 2025-2030: $7 Billion Market Led by Daiichi Sankyo and AstraZeneca, with Rising Competition from Roche, Pfizer/Seagen, ADC Therapeutics

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added...
October 22, 2025 10:09 ET | Source: Research and Markets

Breast Cancer Pipeline Market Research 2025: 300+ Drugs Under Development, Including Innovative Approaches Like PROTACs, ADCs, and CDK Inhibitors

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Breast Cancer - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report delivers in-depth insights into over 250...
May 15, 2025 10:40 ET | Source: Research and Markets

Enhertu Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2024, 2024-2029, 2034F

Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Enhertu Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
May 08, 2025 04:17 ET | Source: Research and Markets

Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts 2019-2034

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Perjeta (Pertuzumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's...
February 12, 2025 04:04 ET | Source: Research and Markets

$22.68 Bn Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has been added to ...
December 02, 2024 10:16 ET | Source: Research and Markets

Breast Cancer Therapeutics Global Market Research 2024: Advancements in Targeted and Immunotherapies Revolutionize Treatment - Forecasts to 2030

Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Breast Cancer Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.This global report on Breast Cancer...
September 25, 2024 04:09 ET | Source: Research and Markets

HER2 Positive Breast Cancer Treatment Pipeline Landscape 2024: Insight Report Reveals Over 60 Companies Developing Innovative Therapies

Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "HER2 Positive Breast Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The report encompasses an in-depth...
January 24, 2024 10:38 ET | Source: Research and Markets

New Research Publication Sheds Light on Metastatic HR+/HER2- Breast Cancer Market Dynamics and 2032 Forecast

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032" report has been added to ResearchAndMarkets.com's...
January 24, 2024 10:35 ET | Source: Research and Markets

HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
December 14, 2023 11:03 ET | Source: Research and Markets

Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics

Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The breast cancer drugs market size is set to to...